FI772280A - - Google Patents

Info

Publication number
FI772280A
FI772280A FI772280A FI772280A FI772280A FI 772280 A FI772280 A FI 772280A FI 772280 A FI772280 A FI 772280A FI 772280 A FI772280 A FI 772280A FI 772280 A FI772280 A FI 772280A
Authority
FI
Finland
Application number
FI772280A
Other languages
Finnish (fi)
Other versions
FI64377C (fi
FI64377B (fi
Inventor
Yoshio Kuroda
Masakuni Okuhara
Eiko Iguchi
Hatsuo Aoki
Hiroshi Imanaka
Takashi Kamiya
Masashi Hashimoto
Keiji Hemmi
Hidekazu Takeno
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI772280A publication Critical patent/FI772280A/fi
Priority to FI821745A priority Critical patent/FI70594C/fi
Application granted granted Critical
Publication of FI64377B publication Critical patent/FI64377B/fi
Publication of FI64377C publication Critical patent/FI64377C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826—Acyclic unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
FI772280A 1976-07-27 1977-07-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminokolvaetefosfonsyraderivat FI64377C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI821745A FI70594C (fi) 1976-07-27 1982-05-18 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminkolvaetefosfonsyraderivat

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB3133976 1976-07-27
GB3133976 1976-07-27
GB4222276 1976-10-11
GB4222276 1976-10-11
GB31339/76A GB1580899A (en) 1976-07-27 1977-06-20 Hydroxyaminohydrocarbonphosphonic acid derivatives and production and use thereof
GB2570077 1977-06-20

Publications (3)

Publication Number Publication Date
FI772280A true FI772280A (fr) 1978-01-28
FI64377B FI64377B (fi) 1983-07-29
FI64377C FI64377C (fi) 1983-11-10

Family

ID=27258468

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772280A FI64377C (fi) 1976-07-27 1977-07-26 Foerfarande foer framstaellning av farmakologiskt vaerdefulla hydroxiaminokolvaetefosfonsyraderivat

Country Status (21)

Country Link
US (1) US4182758A (fr)
JP (1) JPS5340720A (fr)
AR (1) AR226522A1 (fr)
AT (2) AT367064B (fr)
CA (1) CA1091241A (fr)
CH (5) CH640862A5 (fr)
DE (2) DE2733658A1 (fr)
DK (1) DK149609C (fr)
ES (3) ES461084A1 (fr)
FI (1) FI64377C (fr)
FR (1) FR2474505A1 (fr)
GB (1) GB1580899A (fr)
GR (1) GR61140B (fr)
HU (1) HU182023B (fr)
IE (1) IE45536B1 (fr)
NL (1) NL7708325A (fr)
NO (1) NO157504C (fr)
OA (1) OA05725A (fr)
PH (1) PH14401A (fr)
PT (1) PT66854B (fr)
SE (1) SE441360B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4084953A (en) * 1977-03-09 1978-04-18 Monsanto Company N-hydroxy-N-phosphonomethylglycines and the herbicidal use thereof
US4210635A (en) * 1978-02-15 1980-07-01 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition
US4693742A (en) * 1983-12-20 1987-09-15 Rohm And Hass Company Herbicidal hydroxyamino phosphonic acids and derivatives
US5189030A (en) * 1985-06-11 1993-02-23 Ciba-Geigy Corporation 1-amino-2-phenylethanephosphonic acids as microbiocides
JPH0340299U (fr) * 1989-08-31 1991-04-18
CN1297352A (zh) 1998-04-14 2001-05-30 哈桑·朱马 有机磷化合物在治疗和预防性治疗感染中的应用
DE19825585A1 (de) * 1998-04-14 1999-10-21 Hassan Jomaa Verwendung von Aminohydrocarbylphosphonsäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen, die durch Parasiten, Pilze oder Viren hervorgerufen werden
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
US6753324B2 (en) 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
EE200100027A (et) 1998-07-15 2002-06-17 Jomaa Hassan Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
AU5034899A (en) * 1998-07-15 2000-02-07 Jomaa Hassan Drugs containing phosphoric acid derivatives as active ingredient and their use
DE19854403A1 (de) * 1998-11-25 2000-05-31 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
WO2001060829A1 (fr) * 2000-02-18 2001-08-23 Jomaa Pharmaka Gmbh Composes organophosphores et leur utilisation
DE10035189A1 (de) * 2000-07-20 2002-02-21 Hassan Jomaa Arzneimittel zur oralen Applikation mit einem Gehalt an 3-N-Formylhydroxylaminopropylphosphonsäureestern oder 3-N-Acetylhydroxylaminopropylphosphonsäureestern als Wirkstoff
CN101282730A (zh) * 2005-10-06 2008-10-08 依奈特制药公司 有机碱的磷酸抗原盐及其结晶方法
JP5198877B2 (ja) * 2006-01-31 2013-05-15 株式会社エーピーアイ コーポレーション ベンゾアゼピノン類の製造方法
US8580859B2 (en) 2008-08-01 2013-11-12 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
EP2404601A1 (fr) 2010-07-06 2012-01-11 BioAgency AG Nouvelles combinaisons de médicaments pour le traitement du paludisme
EP2725029A1 (fr) * 2012-10-29 2014-04-30 Laboratoire Biodim Nouveaux composés antibactériens et leurs applications biologiques
WO2019246119A1 (fr) * 2018-06-18 2019-12-26 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Antibiotiques destinés aux infections staphylococciques vétérinaires
US20220401462A1 (en) 2019-10-19 2022-12-22 Dmg Deutsche Malaria Gmbh Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives with clindamycin and artesunate
EP3960176A1 (fr) 2020-08-26 2022-03-02 DMG Deutsche Malaria GmbH Piperaquine et combinaisons de médicaments apparentés pour leur utilisation dans le traitement du covid-19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6905272A (fr) 1968-05-15 1969-11-18
US3764677A (en) * 1971-06-25 1973-10-09 Gates Rubber Co Diethyl betaaminoethylphosphonate as an antimicrobial agent

Also Published As

Publication number Publication date
PT66854B (en) 1978-12-28
DK149609C (da) 1987-02-09
CA1091241A (fr) 1980-12-09
ATA564879A (de) 1981-11-15
CH646979A5 (de) 1984-12-28
CH646980A5 (de) 1984-12-28
US4182758A (en) 1980-01-08
FR2474505A1 (fr) 1981-07-31
DK337877A (da) 1978-01-28
CH640862A5 (de) 1984-01-31
JPS5340720A (en) 1978-04-13
DK149609B (da) 1986-08-11
DE2733658C2 (fr) 1987-06-25
NO157504B (no) 1987-12-21
PH14401A (en) 1981-06-25
OA05725A (fr) 1981-05-31
JPS613799B2 (fr) 1986-02-04
GR61140B (en) 1978-09-23
DE2733658A1 (de) 1978-02-09
PT66854A (en) 1977-08-01
GB1580899A (en) 1980-12-10
FR2474505B1 (fr) 1984-01-27
ES479211A1 (es) 1979-12-16
IE45536L (en) 1978-01-27
ES471822A1 (es) 1979-10-16
NO157504C (no) 1988-03-30
ES461084A1 (es) 1978-12-01
CH646978A5 (de) 1984-12-28
ATA550977A (de) 1981-10-15
NL7708325A (nl) 1978-01-31
AT367430B (de) 1982-07-12
IE45536B1 (en) 1982-09-22
FI64377C (fi) 1983-11-10
NO772652L (no) 1978-01-30
DE2760320C2 (fr) 1988-11-03
CH647807A5 (de) 1985-02-15
SE7708592L (sv) 1978-01-28
FI64377B (fi) 1983-07-29
AR226522A1 (es) 1982-07-30
HU182023B (en) 1983-12-28
SE441360B (sv) 1985-09-30
AT367064B (de) 1982-05-25

Similar Documents

Publication Publication Date Title
FR2474505B1 (fr)
CH637799B (fr)
FR2366368B1 (fr)
JPS5531171Y2 (fr)
JPS5536694Y2 (fr)
FR2369174B3 (fr)
JPS5521524Y2 (fr)
JPS5294001U (fr)
CS178379B1 (fr)
JPS52115227U (fr)
JPS52127480U (fr)
JPS5293782U (fr)
JPS5346603U (fr)
CH613476A5 (fr)
CH604445A5 (fr)
DD123551A1 (fr)
DD123521A1 (fr)
DD123560A1 (fr)
DD123165A1 (fr)
CH614803A5 (fr)
CH614104A5 (fr)
CH613774A5 (fr)
DD123950A1 (fr)
CH613068A5 (fr)
CH612100A5 (fr)

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO. LTD.